Benzinga's Top Initiations By: Benzinga via Benzinga December 24, 2014 at 09:08 AM EST Analysts at MLV & Co initiated coverage on Halozyme Therapeutics, Inc. (NASDAQ: HALO) with a Buy rating. The target price for Halozyme ... Read More >> Related Stocks: Ellington Financial Llc Halozyme Therapeutic